Effects of ketamine on proinflammatory cytokines and nuclear factor kappaB in polymicrobial sepsis rats

World Journal of Gastroenterology

Volumn 12, Issue 45, 2006, Pages 7350-7354

  Song, Xue Min ^a   Li, Jian Guo ^a   Wang, Yan Lin ^a   Zhou, Qing ^a   Du, Zhao Hui ^a   Jia, Bao Hui ^a   Ke, Jian Juan ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Hemodynamics; Interleukin 6; Ketamine; Nuclear factor kappa B; Sepsis; Tumor necrosis factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; KETAMINE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMORAL ARTERY; HEART RATE; HEMODYNAMICS; HYPOTENSION; IMAGE ANALYSIS; LIVER HOMOGENATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PHLEBOTOMY; PROTECTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RAT STRAIN; SEPSIS; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

EID: 33845512313     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i45.7350     Document Type: Article

References (17)

1. Matot I, Sprung CL. Definition of sepsis. Intensive Care Med 2001; 27: Suppl 1: S3-S9
2. Glauser MP. Pathophysiologic basis of sepsis: considerations for future strategies of intervention. Crit Care Med 2000; 28: S4-S8
3. Abraham E. NF-kappaB activation. Crit Care Med 2000; 28: N100-N104
4. Takenaka I, Ogata M, Koga. K, Matsumoto T, Shigematsu A. Ketamine suppresses endotoxin-induced tumor necrosis factor alpha production in mice. Anesthesiology 1994; 80: 402-408
5. Taniguchi T, Shibata K, Yamamoto K. Ketamine inhibits endotoxin-induced shock in rats. Anesthesiology 2001; 95: 928-932
6. Kawasaki T, Ogata M, Kawasaki C, Ogata J, Inoue Y, Shigematsu A. Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro. Anesth Analg 1999; 89: 665-669
7. Kawasaki C, Kawasaki T, Ogata. M, Nandate K, Shigematsu A. Ketamine isomers suppress superantigen-induced proinflammatory cytokine production in human whole blood. Can J Anaesth 2001; 48: 819-823
8. Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock - a review of laboratory models and a proposal. J Surg Res 1980; 29: 189-201
9. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 1991; 19: 2499
10. Hoff G, Bauer I, Larsen B, Bauer M. Modulation of endotoxin-stimulated TNF-alpha gene expression by ketan-dne and propofol in cultured human whole blood. Anaesthesist 2001; 50: 494-499
11. Koo DJ, Zhou M, Jackman D, Cioffi WG, Bland KI, Chaudry IH, Wang P. Is gut the major source of proinflammatory cytokine release during polymicrobial sepsis? Biochim Biophys Acta 1999; 1454: 289-295
12. Sakai T, Ichiyama T, Whitten CW, Giesecke AH, Lipton JM. Ketamine suppresses endotoxin-induced NF-kappaB expression. Can J Anaesth 2000; 47: 1019-1024
13. Sun J, Li F, Chen J, Xu J. Effect of ketamine on NF-kappa B activity and TNF-alpha production in endotoxin-treated rats. Ann Clin Lab Sci 2004; 34: 181-186
14. Suliburk JW, Helmer KS, Gonzalez EA, Robinson EK, Mercer DW. Ketamine attenuates liver injury attributed to endotoxemia: role of cyclooxygenase-2. Surgery 2005; 138: 134-140
15. Yang J, Li W, Duan M, Zhou Z, Lin N, Wang Z, Sun J, Xu J. Large dose ketamine inhibits lipopolysaccharide-induced acute lung injury in rats. Inflamm Res 2005; 54: 133-137
16. Brightbill HD, Modlin RL. Toll-like receptors: molecular mechanisms of the mammalian immune response. Immunology 2000; 101: 1-10
17. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406: 782-787